SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment
RNAi에 의한 SARS-CoV-2 표적화 및 숙주 보체 억제: COVID-19 치료를 위한 두 갈래의 속임수
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
approach
C3a
clinical manifestation
clinical manifestations
complement
Complement inhibitor
component
conjunction
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID‐19
COVID‐19 patients
curtail
cytokine
Cytokine storm
degrade
detrimental
Disease progression
disease progression and severity
downstream
effective
Evidence
exacerbate
gene regulation processes
globe
Host
immune responses
infections
information
inhibitor
knowledge
lack
less
Local
mitigate
molecules
ORF
Perspective
preventive measure
preventive measures
progression
Proinflammatory cytokine
protective immunity
Replication
required
respiratory
Result
RNA interference
RNAi
robust
SARS‐CoV‐2
severe acute respiratory syndrome Coronavirus
severity
Spread
suppress
symptomatic and asymptomatic
systemic immune response
systemic immune responses
the cytokine storm
transcript
transmissible variant
Treatment
vaccinate
Vaccine
variants
Viral
viral spread
viral/retroviral
virus
[DOI] 10.1002/iid3.549 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/iid3.549 PMC 바로가기 [Article Type] Review